Grant: Engage Grants Program
University of Waterloo
$25,000.00
Reducing hospital acquired infections: elucidating the biocidal properties and mechanisms of novel copper containing materials
EF 2016-17
Résumé
Aereus Technologies (Aereus), is an Ontario-based innovative company incorporated in 2009 that is commercializing Aereus Shield. Their patented process produces a durable, attractive coating proven to kill harmful bacteria on contact. In Canada, Aereus Shield is marketed as an antimicrobial for use exclusively on Class I and Class II medical devices. Their coating provides a cost-effective intervention against common hospital pathogens and is an ideal solution for high touch public surface. However, microbial pathogens are not the only microbes of concern. Viruses can survive on surfaces and can lead to the spread of infection in high risk settings such as hospitals. Through this grant, a greater understanding of the mechanisms at play in the interaction between two prototypical viruses and novel material coatings prepared by Aereus. The two prototypical viruses, Influenza and Adenovirus, represent two broad classes of viruses, namely enveloped and nonenveloped viruses, and will serve as the basis to initiate a relationship between Aereus and the Aucoin Lab at the University of Waterloo. Together, Aereus and Aucoin will tackle the problem of nosocomial infections by first deepening an understanding of Aereus materials and then utilizing this understanding to better design novel products. Specifically, Aucoin will be setting up a well-controlled environmental chamber in which factors such as temperature and humidity can be controlled and isolated from the biocidal properties of the Aereus materials. These materials are primarily copper-based and present themselves as coatings on metal substrates, as powders and as polymeric composites. The Aucoin group will focus on the coatings and powder in a first part before extending their findings to the analysis of the polymeric composites. Aucoin's work on the stability and quantification of viruses is properly suited to aid Aereus position itself as a unique producer of biocidal materials. Aereus is in a position to capitalize on the scientific findings given existing commercial agreements for their coatings exhibiting anti-microbial properties.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
493795-2016
Name nom
Aucoin, Marc
Department département
Chemical Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1802
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Biochemical engineering
Research subject fr
Génie biochimique
Partie
1
Nb partie
1
Application title
Reducing hospital acquired infections: elucidating the biocidal properties and mechanisms of novel copper containing materials
Keyword
NSERC
Application summary
Aereus Technologies (Aereus), is an Ontario-based innovative company incorporated in 2009 that is commercializing Aereus Shield. Their patented process produces a durable, attractive coating proven to kill harmful bacteria on contact. In Canada, Aereus Shield is marketed as an antimicrobial for use exclusively on Class I and Class II medical devices. Their coating provides a cost-effective intervention against common hospital pathogens and is an ideal solution for high touch public surface. However, microbial pathogens are not the only microbes of concern. Viruses can survive on surfaces and can lead to the spread of infection in high risk settings such as hospitals. Through this grant, a greater understanding of the mechanisms at play in the interaction between two prototypical viruses and novel material coatings prepared by Aereus. The two prototypical viruses, Influenza and Adenovirus, represent two broad classes of viruses, namely enveloped and nonenveloped viruses, and will serve as the basis to initiate a relationship between Aereus and the Aucoin Lab at the University of Waterloo. Together, Aereus and Aucoin will tackle the problem of nosocomial infections by first deepening an understanding of Aereus materials and then utilizing this understanding to better design novel products. Specifically, Aucoin will be setting up a well-controlled environmental chamber in which factors such as temperature and humidity can be controlled and isolated from the biocidal properties of the Aereus materials. These materials are primarily copper-based and present themselves as coatings on metal substrates, as powders and as polymeric composites. The Aucoin group will focus on the coatings and powder in a first part before extending their findings to the analysis of the polymeric composites. Aucoin's work on the stability and quantification of viruses is properly suited to aid Aereus position itself as a unique producer of biocidal materials. Aereus is in a position to capitalize on the scientific findings given existing commercial agreements for their coatings exhibiting anti-microbial properties.